Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

NCT06790225 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Bone Disease, Metabolic
Diabetes Mellitus, Type 2
Obesity and Obesity-related Medical Conditions

Interventions

OTHER: Glucose-dependent Insulinotropic Polypeptide (GIP)

Sponsor

Esbjerg Hospital - University Hospital of Southern Denmark